Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- RinvaterceptKER-065Phase 21 trial
Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy
- RL-007InidascaminePhase 21 trial
Recognify Life Sciences · Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia
- RLY-2608Phase 21 trial
Relay Therapeutics, Inc. · PIK3CA-Related Overgrowth Spectrum (PROS), Lymphatic Malformations, Vascular Malformations
- RLY-8161Phase 21 trial
Relay Therapeutics, Inc. · Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors, NRAS Mutation
- RMC-035Phase 21 trial
Guard Therapeutics AB · Kidney Injury Following Open-Chest Cardiac Surgery
- RN0361Phase 21 trial
Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome
- RN3161Phase 21 trial
Ikaria Bioscience Pty Ltd · Obesity &Amp; Overweight
- RNDP-001Phase 21 trial
Kenai Therapeutics · Idiopathic Parkinson´s Disease, Parkinson's Disease
- RNK05047Phase 21 trial
Ranok Therapeutics (Hangzhou) Co., Ltd. · Advanced Solid Tumor, DLBCL
- RNK08954-01Phase 21 trial
Ranok Therapeutics (Hangzhou) Co., Ltd. · KRAS G12D Mutation
- RO0091978Phase 21 trial
Roche (Genentech) · Metastatic Breast Cancer
- RO6874281Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- RO7268489Phase 21 trial
Roche (Genentech) · Progressive Multiple Sclerosis
- RO7269162Phase 21 trial
Roche (Genentech) · Alzheimer's Disease
- RO7275887Phase 21 trial
Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
- RO7446603Phase 21 trial
Roche (Genentech) · Diabetic Macular Edema
- RO7830698Phase 21 trial
Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
- RO7837195Phase 21 trial
Roche (Genentech) · Ulcerative Colitis
- RO7965032Phase 21 trial
Roche (Genentech) · Geographic Atrophy Secondary to Age-Related Macular Degeneration
- ROC-101Phase 21 trial
AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease
- RP-001Phase 21 trial
Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer
- RP902Phase 21 trial
Risen (Suzhou) Pharma Tech Co., Ltd. · Mild Cognitive Impairment (MCI)
- RR001Phase 21 trial
EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma
- RRG001Phase 21 trial
Shanghai Refreshgene Technology Co., Ltd. · Neovascular Age-related Macular Degeneration
- RRx-001Phase 21 trial
EpicentRx, Inc. · Oral Mucositis
- RS-113Phase 21 trial
R-Pharm International, LLC · Metastatic Castration-resistant Prostate Cancer
- RSLV-132Phase 21 trial
Resolve Therapeutics · Primary Sjögren Syndrome
- RSO-021ThiostreptonPhase 21 trial
RS Oncology LLC · Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma
- RSP-1502Phase 21 trial
Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa
- RSS0343Phase 21 trial
Reistone Biopharma Company Limited · Chronic Obstructive Pulmonary Disease
- RT023Phase 21 trial
Shanghai Ruotuo Biosciences Co., Ltd. · Advanced Malignant Solid Tumours
- RT036Phase 21 trial
Shanghai Ruotuo Biosciences Co., Ltd. · Advanced Malignant Solid Tumours
- RTN-001SLx-2101Phase 21 trial
Retension Pharmaceuticals. Inc. · Uncontrolled Hypertension
- RTP-026Phase 21 trial
ResoTher Pharma · ST Elevation Myocardial Infarction
- RuzasvirAT-038Phase 21 trial
Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C
- RV001VPhase 21 trial
RhoVac APS · Prostate Cancer Recurrent
- RVP-001Mn-PyC3A, mangaveratePhase 21 trial
Reveal Pharmaceuticals Inc. · Central Nervous System (CNS) Lesions, Brain Metastases, Brain Neoplasms
- RXC007Phase 21 trial
Redx Pharma Ltd · IPF, Fibrosis
- RXRG001Phase 21 trial
RiboX Therapeutics Ltd. · Radiation-Induced Xerostomia and Hyposalivation
- RYZ711Phase 21 trial
RayzeBio, Inc. · Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- RYZ801Phase 21 trial
RayzeBio, Inc. · Hepatocellular Carcinoma (HCC)
- S095018Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095024Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095035Phase 21 trial
Servier Bio-Innovation LLC · MTAP-deleted Solid Tumors
- S241656Phase 21 trial
Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia
- S243249Phase 21 trial
Servier · Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Myeloid Leukemia
- S247240Phase 21 trial
Institut de Recherches Internationales Servier (I.R.I.S.) · Fragile X Syndrome (FXS)
- SA53-OSPhase 21 trial
Lamassu Bio Inc · Solid Tumor
- SAB-142Phase 21 trial
SAb Biotherapeutics, Inc. · Type 1 Diabetes
- sabatolimabMBG453Phase 21 trial
Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.